Literature DB >> 23035218

Infection and propagation of human rhinovirus C in human airway epithelial cells.

Weidong Hao1, Katie Bernard, Nita Patel, Nancy Ulbrandt, Hui Feng, Catherine Svabek, Susan Wilson, Christina Stracener, Kathy Wang, Joann Suzich, Wade Blair, Qing Zhu.   

Abstract

Human rhinovirus species C (HRV-C) was recently discovered using molecular diagnostic techniques and is associated with lower respiratory tract disease, particularly in children. HRV-C cannot be propagated in immortalized cell lines, and currently sinus organ culture is the only system described that is permissive to HRV-C infection ex vivo. However, the utility of organ culture for studying HRV-C biology is limited. Here, we report that a previously described HRV-C derived from an infectious cDNA, HRV-C15, infects and propagates in fully differentiated human airway epithelial cells but not in undifferentiated cells. We demonstrate that this differentiated epithelial cell culture system supports infection and replication of a second virus generated from a cDNA clone, HRV-C11. We show that HRV-C15 virions preferentially bind fully differentiated airway epithelial cells, suggesting that the block to replication in undifferentiated cells is at the step of viral entry. Consistent with previous reports, HRV-C15 utilizes a cellular receptor other than ICAM-1 or LDLR for infection of differentiated epithelial cells. Furthermore, we demonstrate that HRV-C15 replication can be inhibited by an HRV 3C protease inhibitor (rupintrivir) but not an HRV capsid inhibitor previously under clinical development (pleconaril). The HRV-C cell culture system described here provides a powerful tool for studying the biology of HRV-C and the discovery and development of HRV-C inhibitors.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23035218      PMCID: PMC3503113          DOI: 10.1128/JVI.02094-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Quantitative real-time PCR for rhinovirus, and its use in determining the relationship between TCID50 and the number of viral particles.

Authors:  Lorne A Sachs; David Schnurr; Shigeo Yagi; Marrah E Lachowicz-Scroggins; Jonathan H Widdicombe
Journal:  J Virol Methods       Date:  2010-11-09       Impact factor: 2.014

2.  Clinical spectrum of human rhinovirus infections in hospitalized Hong Kong children.

Authors:  Rainbow K Y Mak; Lai Y Tse; Wai Y Lam; Gary W K Wong; Paul K S Chan; Ting F Leung
Journal:  Pediatr Infect Dis J       Date:  2011-09       Impact factor: 2.129

3.  Respiratory syncytial virus infection of human airway epithelial cells is polarized, specific to ciliated cells, and without obvious cytopathology.

Authors:  Liqun Zhang; Mark E Peeples; Richard C Boucher; Peter L Collins; Raymond J Pickles
Journal:  J Virol       Date:  2002-06       Impact factor: 5.103

4.  Phylogenetic patterns of human respiratory picornavirus species, including the newly identified group C rhinoviruses, during a 1-year surveillance of a hospitalized patient population in Italy.

Authors:  Antonio Piralla; Fausto Baldanti; Giuseppe Gerna
Journal:  J Clin Microbiol       Date:  2010-11-10       Impact factor: 5.948

5.  Phase II, randomized, double-blind, placebo-controlled studies of ruprintrivir nasal spray 2-percent suspension for prevention and treatment of experimentally induced rhinovirus colds in healthy volunteers.

Authors:  Frederick G Hayden; Ronald B Turner; Jack M Gwaltney; Kathy Chi-Burris; Merril Gersten; Poe Hsyu; Amy K Patick; George J Smith; Leora S Zalman
Journal:  Antimicrob Agents Chemother       Date:  2003-12       Impact factor: 5.191

6.  Molecular modeling, organ culture and reverse genetics for a newly identified human rhinovirus C.

Authors:  Yury A Bochkov; Ann C Palmenberg; Wai-Ming Lee; Jennifer A Rathe; Svetlana P Amineva; Xin Sun; Thomas R Pasic; Nizar N Jarjour; Stephen B Liggett; James E Gern
Journal:  Nat Med       Date:  2011-04-10       Impact factor: 53.440

7.  Human rhinovirus infection in young African children with acute wheezing.

Authors:  Heidi E Smuts; Lesley J Workman; Heather J Zar
Journal:  BMC Infect Dis       Date:  2011-03-15       Impact factor: 3.090

8.  Human rhinovirus infections in rural Thailand: epidemiological evidence for rhinovirus as both pathogen and bystander.

Authors:  Alicia M Fry; Xiaoyan Lu; Sonja J Olsen; Malinee Chittaganpitch; Pongpun Sawatwong; Somrak Chantra; Henry C Baggett; Dean Erdman
Journal:  PLoS One       Date:  2011-03-29       Impact factor: 3.240

9.  Efficacy and safety of oral pleconaril for treatment of colds due to picornaviruses in adults: results of 2 double-blind, randomized, placebo-controlled trials.

Authors:  Frederick G Hayden; Darrell T Herrington; Teresa L Coats; Kenneth Kim; Ellen C Cooper; Stephen A Villano; Siyu Liu; Spencer Hudson; Daniel C Pevear; Marc Collett; Mark McKinlay
Journal:  Clin Infect Dis       Date:  2003-06-06       Impact factor: 9.079

Review 10.  Rhinovirus and the lower respiratory tract.

Authors:  Frederick G Hayden
Journal:  Rev Med Virol       Date:  2004 Jan-Feb       Impact factor: 6.989

View more
  45 in total

1.  Production, purification, and capsid stability of rhinovirus C types.

Authors:  Theodor F Griggs; Yury A Bochkov; Kazuyuki Nakagome; Ann C Palmenberg; James E Gern
Journal:  J Virol Methods       Date:  2015-02-24       Impact factor: 2.014

2.  Multiple classes of antiviral agents exhibit in vitro activity against human rhinovirus type C.

Authors:  Chris Mello; Esmeralda Aguayo; Madeleine Rodriguez; Gary Lee; Robert Jordan; Tomas Cihlar; Gabriel Birkus
Journal:  Antimicrob Agents Chemother       Date:  2013-12-23       Impact factor: 5.191

3.  Modeling of the human rhinovirus C capsid suggests possible causes for antiviral drug resistance.

Authors:  Holly A Basta; Shamaila Ashraf; Jean-Yves Sgro; Yury A Bochkov; James E Gern; Ann C Palmenberg
Journal:  Virology       Date:  2013-10-20       Impact factor: 3.616

4.  Immunodominant T-Cell Epitopes in the VP1 Capsid Protein of Rhinovirus Species A and C.

Authors:  Cibele M Gaido; Shane Stone; Abha Chopra; Wayne R Thomas; Peter N Le Souëf; Belinda J Hales
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

5.  Phosphatidylinositol 4-kinase III beta is essential for replication of human rhinovirus and its inhibition causes a lethal phenotype in vivo.

Authors:  Catherine Spickler; Julie Lippens; Marie-Kristine Laberge; Sophie Desmeules; Édith Bellavance; Michel Garneau; Tim Guo; Oliver Hucke; Pieter Leyssen; Johan Neyts; Fréderic H Vaillancourt; Anne Décor; Jeff O'Meara; Michael Franti; Annick Gauthier
Journal:  Antimicrob Agents Chemother       Date:  2013-05-06       Impact factor: 5.191

6.  Cadherin-related family member 3, a childhood asthma susceptibility gene product, mediates rhinovirus C binding and replication.

Authors:  Yury A Bochkov; Kelly Watters; Shamaila Ashraf; Theodor F Griggs; Mark K Devries; Daniel J Jackson; Ann C Palmenberg; James E Gern
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-06       Impact factor: 11.205

7.  Classification and evolution of human rhinoviruses.

Authors:  Ann C Palmenberg; James E Gern
Journal:  Methods Mol Biol       Date:  2015

8.  Reverse genetics system for studying human rhinovirus infections.

Authors:  Wai-Ming Lee; Wensheng Wang; Yury A Bochkov; Iris Lee
Journal:  Methods Mol Biol       Date:  2015

9.  Chimeric rhinoviruses obtained via genetic engineering or artificially induced recombination are viable only if the polyprotein coding sequence derives from the same species.

Authors:  Manuel Schibler; Isabelle Piuz; Weidong Hao; Caroline Tapparel
Journal:  J Virol       Date:  2015-02-04       Impact factor: 5.103

10.  Effects of rhinovirus species on viral replication and cytokine production.

Authors:  Kazuyuki Nakagome; Yury A Bochkov; Shamaila Ashraf; Rebecca A Brockman-Schneider; Michael D Evans; Thomas R Pasic; James E Gern
Journal:  J Allergy Clin Immunol       Date:  2014-03-14       Impact factor: 10.793

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.